Assessments and Phenotypes in Mental Health

In this exciting webinar series we take a deep dive into innovations in the field of psychiatry, relating to the use of specified assessment tools. Mary and Steven Rondeau will explore the use of translational neuro-imaging, blood work and functional medicine lab work to assess psychiatric conditions and to determine the most effective treatment guidelines for your patients.    

The course will begin with an overview of the use of translational neuro-imaging such as quantitative electroencephalography (qEEG). QEEG is also called “brain mapping” as it creates a visual map of the electrical activity in the brain. In simple terms, the test measures brainwaves the same way an electrocardiogram measures the heart’s electrical activity. Numerous studies now demonstrate qEEG’s use to aid in diagnosis, predict treatment response, monitor changes with therapies. The American Academy of Neurology and the American Clinical Neurophysiology Society support the use of qEEG for various conditions.

This is the next frontier in psychiatry; the only field that doesn’t routinely test the organ it is treating. The use of qEEG provides objective data in psychiatric assessments and has led to the discovery of subtypes of conditions once thought of as homogenous such as anxiety and depression.  In additional this assessment tool may clarify why various medications fail even when clinically indicated.

The course will then explore the use of blood work and functional medicine lab work up to assess psychiatric conditions. This series will help clinicians use more objective data points to assist with treatment planning for mental health conditions.

Following this update, the course will provide detailed analysis of the phenotypes of depression, attention issues and anxiety. Importantly, your presenters will give guidance on how to prepare comprehensive treatments plans for these phenotypes.